HALB (Halberd) EV-to-EBITDA: (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Halberd EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Halberd's enterprise value is $0.64 Mil. Halberd does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Jul. 2023. Therefore, GuruFocus does not calculate Halberd's EV-to-EBITDA at this moment.

The historical rank and industry rank for Halberd's EV-to-EBITDA or its related term are showing as below:

HALB' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1.59   Med: 0   Max: 0
Current: -1.43

HALB's EV-to-EBITDA is not ranked
in the Biotechnology industry.
Industry Median: 11.905 vs HALB: -1.43

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-02), Halberd's stock price is $0.0009. Halberd does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2023. Therefore, GuruFocus does not calculate Halberd's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Halberd  (OTCPK:HALB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Halberd's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0009/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Halberd EV-to-EBITDA Related Terms


Halberd EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Halberd's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Halberd EV-to-EBITDA Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
EV-to-EBITDA
0.00 -4.04 -12.63

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
EV-to-EBITDA 0.00 -4.04 -12.63

HALB vs GRI, OCEA, PCSA: EV-to-EBITDA Comparison

For the Biotechnology subindustry, Halberd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Halberd EV-to-EBITDA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Halberd's EV-to-EBITDA falls into.



Halberd EV-to-EBITDA Calculation

Halberd's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.637/
=


Halberd Business Description

Address P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.